CG Oncology Inc. Common s...

NASDAQ: CGON · Real-Time Price · USD
25.74
-0.22 (-0.85%)
At close: Aug 15, 2025, 3:05 PM

CG Oncology Common stock Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
1.14M 204K 191K 10.36M
Cost of Revenue
n/a 17K 15K 10K
Gross Profit
1.14M 204K 176K 10.35M
Operating Income
-114.67M -55.45M -35.25M -12.61M
Interest Income
26.62M 6.9M n/a n/a
Pretax Income
-88.04M -48.61M -35.44M -12.84M
Net Income
-88.04M -48.61M -35.44M -12.84M
Selling & General & Admin
33.7M 9.9M 6.39M 4.63M
Research & Development
82.1M 45.75M 29.03M 18.32M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
115.81M 55.65M 35.42M 22.95M
Interest Expense
n/a n/a 1K 451K
Selling & Marketing Expenses
n/a n/a -15K -10K
Cost & Expenses
115.81M 55.65M 35.44M 22.96M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
62.5M 66.64M 66.64M 66.64M
Shares Outstanding (Diluted)
62.5M 66.64M 66.64M 66.64M
EPS (Basic)
-1.41 -1.02 -0.66 -0.28
EPS (Diluted)
-1.41 -1.02 -0.66 -0.28
EBITDA
-114.63M -55.43M -35.23M -12.38M
EBIT
-114.67M -55.45M -35.25M -12.39M
Depreciation & Amortization
32K 17K 15K 10K